| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,743 |
15,818 |
$1.16M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,257 |
3,101 |
$325K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,275 |
2,234 |
$225K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,053 |
2,007 |
$198K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,301 |
1,225 |
$117K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
974 |
943 |
$110K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
10,067 |
9,688 |
$88K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,294 |
4,115 |
$67K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,446 |
1,379 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
332 |
316 |
$13K |
| 92587 |
|
110 |
108 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
178 |
172 |
$4K |
| 99050 |
|
74 |
72 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
268 |
133 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
217 |
215 |
$2K |
| 96160 |
|
497 |
486 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
121 |
96 |
$2K |
| 96127 |
|
552 |
540 |
$1K |
| 99173 |
|
687 |
686 |
$1K |
| 90686 |
|
400 |
399 |
$192.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$143.19 |
| 90656 |
|
98 |
98 |
$48.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.33 |